NASDAQ:GLMD - Galmed Pharmaceuticals Stock Price, Forecast & News

Galmed Pharmaceuticals trades on the NASDAQ under the ticker symbol "GLMD."

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) released its quarterly earnings results on Wednesday, November, 6th. The biopharmaceutical company reported ($0.21) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.32) by $0.11. View Galmed Pharmaceuticals' Earnings History.

Galmed Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Galmed Pharmaceuticals.

5 equities research analysts have issued 1-year target prices for Galmed Pharmaceuticals' stock. Their forecasts range from $10.00 to $59.00. On average, they anticipate Galmed Pharmaceuticals' share price to reach $30.50 in the next twelve months. This suggests a possible upside of 402.5% from the stock's current price. View Analyst Price Targets for Galmed Pharmaceuticals.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Galmed Pharmaceuticals in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Galmed Pharmaceuticals.

Press coverage about GLMD stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Galmed Pharmaceuticals earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave news headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Galmed Pharmaceuticals.

Galmed Pharmaceuticals saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 465,500 shares, an increase of 6.1% from the November 28th total of 438,700 shares. Based on an average daily trading volume, of 114,900 shares, the short-interest ratio is presently 4.1 days. Currently, 3.2% of the shares of the stock are sold short. View Galmed Pharmaceuticals' Current Options Chain.

Some companies that are related to Galmed Pharmaceuticals include Clovis Oncology (CLVS), Viking Therapeutics (VKTX), Molecular Templates (MTEM), BioDelivery Sciences International (BDSI), Mallinckrodt (MNK), OrganiGram (OGI), Milestone Pharmaceuticals (MIST), Dynavax Technologies (DVAX), CytoDyn (CYDY), Ardelyx (ARDX), Organogenesis (ORGO), Corbus Pharmaceuticals (CRBP), Sinovac Biotech (SVA), Arcus Biosciences (RCUS) and Assembly Biosciences (ASMB).

Based on aggregate information from My MarketBeat watchlists, some companies that other Galmed Pharmaceuticals investors own include Opko Health (OPK), Viking Therapeutics (VKTX), Rite Aid (RAD), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Immunomedics (IMMU), Portola Pharmaceuticals (PTLA), Verastem (VSTM), Micron Technology (MU) and NVIDIA (NVDA).

Shares of GLMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of GLMD stock can currently be purchased for approximately $6.07.

Galmed Pharmaceuticals has a market capitalization of $127.59 million and generates $2.04 million in revenue each year. The biopharmaceutical company earns $-9,860,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis. Galmed Pharmaceuticals employs 17 workers across the globe.View Additional Information About Galmed Pharmaceuticals.

The official website for Galmed Pharmaceuticals is http://www.galmedpharma.com/.

Galmed Pharmaceuticals' mailing address is 16 TIOMKIN STREET, TEL AVIV L3, 6578317. The biopharmaceutical company can be reached via phone at 972-3693-8448.